Lite Strategy Inc (LITS)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.97-9.99%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · LITS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.3 | — | 65.3 | 48.8 | 40.7 | 34.8 | 27.8 | 4.9 | 1.6 | 23.2 | — | — | — | — | — |
| Total Revenues | — | 0.3 | — | 65.3 | 48.8 | 40.7 | 34.8 | 27.8 | 4.9 | 1.6 | 23.2 | — | — | — | — | — |
| Cost of Revenues | — | — | — | — | — | 0.0 | 1.4 | 2.7 | 4.3 | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 0.1 | 0.1 | 3.9 | 16.6 | 52.5 | 85.6 | 69.4 | 34.1 | 32.3 | 17.0 | 7.2 | 13.4 | 23.8 | 19.3 | 6.1 | 4.9 |
| Operating Income | (66.6) | (66.6) | (17.5) | 14.5 | (36.8) | (75.5) | (60.4) | (25.7) | (46.2) | (28.6) | 2.4 | (21.0) | (32.8) | (27.2) | (11.2) | (8.4) |
| Earnings from Continuing Operations | ||||||||||||||||
| Other Non-Operating Income / Expenses | (4.6) | (4.6) | 1.5 | 3.2 | 4.9 | 21.0 | 19.1 | (21.5) | — | — | — | — | — | — | — | 0.9 |
| EBT, Incl. Unusual Items | — | (71.2) | (15.9) | 17.8 | (31.8) | (54.5) | (41.3) | (47.2) | (16.8) | (40.1) | 2.7 | (20.9) | (32.7) | (27.1) | (11.2) | (7.5) |
| Income Tax Expense | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (71.2) | (71.2) | (15.9) | 17.8 | (32.0) | (54.0) | (41.0) | (47.2) | (16.8) | (40.1) | 2.7 | (20.9) | (32.7) | (27.1) | (11.2) | (7.5) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (2.06) | (2.39) | 2.67 | (4.78) | (8.75) | (0.37) | (0.52) | (0.24) | (0.97) | 0.07 | — | — | — | — | — |
| Diluted EPS | — | (2.06) | (2.39) | 2.67 | (4.78) | (9.99) | (0.60) | (0.52) | (0.75) | (0.97) | 0.07 | — | — | — | — | — |
| Dividend per Share | — | — | — | 1.75 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | — | 34.6 | 6.7 | 6.7 | 6.7 | 6.2 | 112.5 | 91.1 | 71.1 | 41.4 | 36.8 | — | — | — | — | — |
| Diluted Weighted Avg Shares | — | 34.6 | 6.7 | 6.7 | 6.7 | 6.3 | 114.5 | 91.1 | 72.4 | 41.4 | 36.9 | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | (17.1) | 14.9 | (36.4) | (75.2) | (60.1) | (25.6) | (46.2) | (28.5) | 2.5 | (20.9) | (32.7) | (27.2) | (11.2) | — |
| EBIT | (66.6) | (66.6) | (17.5) | 14.5 | (36.8) | (75.5) | (60.4) | (25.7) | (46.2) | (28.6) | 2.4 | (21.0) | (32.8) | (27.2) | (11.2) | (8.4) |
| Effective Tax Rate | — | — | — | — | 0.0% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.